SELDI-TOF MS ProteinChip technology for screening of serum markers of HBV-induced hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 505-508

  Geng, X ^a   Wang, F ^a   Li, Y G ^a   Zhu, G P ^a   Zhang, Weiming M ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Protein chip; Proteomics; SELDI; Serum markers

Indexed keywords

ACTIN RELATED PROTEIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CATION; CHEMOKINE; GALANIN; NEU DIFFERENTIATION FACTOR; NEUREGULIN 4; PEPTIDE; PROTEIN; SMALL INDUCIBLE CYTOKINE A15; TUMOR MARKER; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 1;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CATION EXCHANGE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG TARGETING; FEMALE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SCREENING; SERUM; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 38549084705     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Makatsoris T., Petsas T., Tsamandas A.C., et al.: Hepatocellular carcinoma in hepatectomized patients: biologic and therapeutic implications. Anticancer Res., 25, 3067-3073, 2005.
2. Paradis V., Degos F., Dargere D., et al.: Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology, 41, 40-47, 2005.
3. Johnson P.J.: The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin. Liver Dis. 5,145-159, 2001.
4. Reynolds T.: For ptoteomics research ,a new race has begun . J. Natl. Cancer Inst., 94,552-554, 2002.
5. Wu W, HU W, Kavanagh J.: Proteomics in cancer research. Int. J. Gynecol. Cancer, 12,409-423, 2002.
6. Lueking A., Cahill D.J., Mullner S.: Protein biochips: A new and versatile platform technology for molecular medicine. Drug Discov. Today, 10,789-794, 2005.
7. Melle C., Kaufmann R., Hommann M., et al.: Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology. Int. J. Oncol., 24,885-891, 2004.
8. Petricoin E.F., Ardekani A.M., Hitt B.A., et al.: Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359,572-577, 2002.
9. Adam B.L., Qu Y., Davis J.W., et al.: Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62, 3609-3614, 2002.
10. Issaq H.J., Veenstra T.D., Conrads T.P., et al.: The SELDI-TOF MS approach to ptoteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun., 292,587-592, 2002.